Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             657 results found
no title author magazine year volume issue page(s) type
1 Aberrant processing of mutant amyloid precursor protein (APP) leads to altered morphology in cultured cells 1994
 15 S1 p. S56-
1 p.
 article
2 Aβ binding to the precursor of NAC (non-Aβ component of AD amyloid) 1994
 15 S1 p. S49-
1 p.
 article
3 Abnormalities of phospholipase C-delta in Alzheimer's disease 1994
 15 S1 p. S38-
1 p.
 article
4 Abnormal localization of lysosomal hydrolases in diffuse plaques of Alzheimer and down syndrome brains 1994
 15 S1 p. S115-
1 p.
 article
5 Abnormally phosphorylated tau from Alzheimer disease brain depolymerizes microtubules 1994
 15 S1 p. S37-
1 p.
 article
6 Abnormally phosphorylated tau in Alzheimer disease: Biochemical and morphological heterogeneity 1994
 15 S1 p. S139-
1 p.
 article
7 Abnormally phosphorylated tau in SY5Y human neuroblastoma cells and its regulation by phosphatases 1994
 15 S1 p. S77-
1 p.
 article
8 Abnormal properties of acetylcholinesterase inhibitors localized in senile plaque 1994
 15 S1 p. S102-
1 p.
 article
9 Abnormal synaptic regeneration in hAPP transgenic and ApoE knockout mice 1994
 15 S1 p. S11-S12
2 p.
 article
10 ABP (25–35) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cultures 1994
 15 S1 p. S116-
1 p.
 article
11 Absorption, distribution, metabolism, and elimination of radiolabeled xanomeline in healthy male subjects DeLong, AF
 1994
 15 S1 p. S105-
1 p.
 article
12 Acceptability and clinical activity of 4 weeks' treatment by S12024-2 in 53 in-patients with moderate to severe Alzheimer's disease 1994
 15 S1 p. S136-S137
2 p.
 article
13 Accumulation of “Alzheimer” proteins, prion, their mRNAs, and twisted tubulofilaments in muscle fibers of sporadic and hereditary inclusion-body myositis and myopathy: Light- and em-immunocytochemistry and in situ hybridization 1994
 15 S1 p. S113-S114
2 p.
 article
14 A CDEI-like E-box in the APP promoter provides a possible role for APLP2 in transcriptional regulation 1994
 15 S1 p. S86-
1 p.
 article
15 A cholera toxin sensitive protein modulates phorbol ester regulated cleavage and secretion of the Alzheimer's amyloid precursor 1994
 15 S1 p. S85-
1 p.
 article
16 A comparison of acute phase protein expression after head injury with that seen in Alzheimer's disease 1994
 15 S1 p. S116-
1 p.
 article
17 A comparison of the pre- and post-meeting testing recommendations offered by the participants of the Canadian consensus conference on the assessment of dementia: Do consensus conferences influence their participants? 1994
 15 S1 p. S99-
1 p.
 article
18 A comparison of the prevalence of dementia and Alzheimer's disease in community dwelling residents of Ibadan, Nigeria and Indianapolis, U.S.A. 1994
 15 S1 p. S42-
1 p.
 article
19 Activation of second messenger systems can enhance or inhibit the secretion of the amyloid precursor protein (APP) 1994
 15 S1 p. S62-
1 p.
 article
20 Acute phase proteins in sera from older persons with down syndrome and Alzheimer disease 1994
 15 S1 p. S94-
1 p.
 article
21 Adaptation of the Morris water maze for the aging dog 1994
 15 S1 p. S13-
1 p.
 article
22 Adaptation to spousal caregiving: Do race and gender matter? 1994
 15 S1 p. S1-S2
2 p.
 article
23 A decrease of growth inhibitory factor is specific to neuropil thread-bearing dementias 1994
 15 S1 p. S123-
1 p.
 article
24 β/A4 deposition, neural degeneration and synapse pathology in Alzheimer patients of different apolipoprotein E genotypes 1994
 15 S1 p. S117-
1 p.
 article
25 A double-blind, placebo controlled, multi-centre study of tacrine for Alzheimer's disease 1994
 15 S1 p. S99-S100
2 p.
 article
26 Advanced glycosylation endproducts contribute to amyloidosis in alzheimer's disease 1994
 15 S1 p. S79-S80
2 p.
 article
27 Advances in the diagnosis of AD 1994
 15 S1 p. S5-
1 p.
 article
28 AF150S: A selective partial M1 agonist improves cognitive performance in rats 1994
 15 S1 p. S103-
1 p.
 article
29 A functional not epicritical model for examining Alzheimer's disease: Orthogonal structures, hierarchical and linearly-dependent architecture 1994
 15 S1 p. S15-
1 p.
 article
30 Age of onset and genetic predisposition in familial Alzheimer's disease Crawford, F
 1994
 15 S1 p. S128-
1 p.
 article
31 Aggregation and neurotoxicity of amyloid β-protein: acceleration by aluminum 1994
 15 S1 p. S49-S50
2 p.
 article
32 Aggregation of endogenous secreted amyloid beta peptide (Aβ) into SDS-stable multimers 1994
 15 S1 p. S82-
1 p.
 article
33 Aggressive residents in long term care facilities: Report of an intervention study 1994
 15 S1 p. S138-
1 p.
 article
34 A human neuronal culture system for studies of dynamics of tau phosphorylation and microtubule binding 1994
 15 S1 p. S32-
1 p.
 article
35 A leptomeningeal protease releasing the β protein from the β protein precursor of Alzheimer's disease 1994
 15 S1 p. S4-
1 p.
 article
36 ϵ4 allele of the apolipoprotein E gene is a potent risk factor for cognitive impairment 1994
 15 S1 p. S43-
1 p.
 article
37 Alterations in parameters of lipid peroxidation in postmortem Alzheimer's disease brain 1994
 15 S1 p. S125-
1 p.
 article
38 Alterations in the neuronal cytoskeleton following in vivo administration of a metabolic inhibitor, 3-nitropropionic acid 1994
 15 S1 p. S25-
1 p.
 article
39 Alterations in the transmembrane potential of synaptosomes prepared from Alzheimer's disease brains 1994
 15 S1 p. S13-
1 p.
 article
40 Aluminium and copper levels in serum of late onset probable Alzheimer's disease (AD) patients. A case-control study 1994
 15 S1 p. S46-
1 p.
 article
41 Alzheimer disease: from abnormal phosphorylation of tau to neurofibrillary degeneration 1994
 15 S1 p. S31-
1 p.
 article
42 Alzheimer-like pathology produced by sodium azide-induced cytochrome oxidase inhibition: Potentiation by glucocorticoid 1994
 15 S1 p. S15-
1 p.
 article
43 Alzheimer's amyloid β-protein causes degeneration of cultured cerebrovascular smooth muscle cells 1994
 15 S1 p. S55-
1 p.
 article
44 Alzheimer's disease and animal models 1994
 15 S1 p. S5-S6
2 p.
 article
45 Alzheimer's disease and fecundity: An example of antagonistic pleiotrophy? 1994
 15 S1 p. S127-
1 p.
 article
46 Alzheimer's disease and history of blood transfusion 1994
 15 S1 p. S45-S46
2 p.
 article
47 Alzheimer's disease caregiving: Prevalence and health effects 1994
 15 S1 p. S1-
1 p.
 article
48 Alzheimer's disease in adults with Down's syndrome: The relationship between regional cerebral blood flow equivalents and dementia 1994
 15 S1 p. S97-
1 p.
 article
49 Alzheimer's disease-like phosphorylation of tau in cultured cells 1994
 15 S1 p. S77-
1 p.
 article
50 Alzheimer's disease with spheroid pigmentary degeneration in the substantia nigra 1994
 15 S1 p. S111-S112
2 p.
 article
51 Alzheimer's patients wards in Dutch nursing homes, 1981–1993 1994
 15 S1 p. S4-
1 p.
 article
52 A methodology of integrating families with Alzheimer's disease into a scientific research program 1994
 15 S1 p. S108-
1 p.
 article
53 Amyloid βA4 protein and its precursor APP in alzheimer's disease (AD) 1994
 15 S1 p. S75-
1 p.
 article
54 β-amyloid free radical production, peptide fragmentation and neurotoxicity: Implications of molecular shrapnel to the etiology of Alzheimer's disease 1994
 15 S1 p. S70-
1 p.
 article
55 β-amyloid increases membrane conductance of PC12 cells 1994
 15 S1 p. S83-
1 p.
 article
56 β-Amyloid-induced reactive changes in cultured astrocytes parallel astrocytosis associated with senile plaques in Alzheimer's disease 1994
 15 S1 p. S71-
1 p.
 article
57 β-amyloid load in the neocortex of elderly Alzheimer's disease patients 1994
 15 S1 p. S145-
1 p.
 article
58 β-amyloid peptide (1–40) applied to brain lesions enhances neuronal degeneration 1994
 15 S1 p. S14-
1 p.
 article
59 Amyloid precursor-like protein 2 (APLP2) is a chondroitin sulfate proteoglycan: Identification of the glycosaminoglycan modification site 1994
 15 S1 p. S65-
1 p.
 article
60 Amyloid precursor protein expression and β-amyloid release in fibroblast cell lines obtained from family members with the Swedish APP670/671 mutation Johnston, J.
 1994
 15 S1 p. S71-
1 p.
 article
61 Amyloid β-protein (25–35) disrupts plasma membrane ATP-ase activity in cultured rat embryonic cortical neurons 1994
 15 S1 p. S86-
1 p.
 article
62 Amyloid β-protein induces membrane fusion: Structure-function studies 1994
 15 S1 p. S55-
1 p.
 article
63 Amyloids, genes and chaperones in Alzheimer's disease 1994
 15 S1 p. S39-
1 p.
 article
64 Analysis of the prion protein 178ASN mutation linked to fatal familial insomnia and creutzfeldt-jakob disease in a transfected human cell line 1994
 15 S1 p. S156-
1 p.
 article
65 Animal model and in vitro studies of immune mediated neurodegeneration in Alzheimer's disease 1994
 15 S1 p. S33-
1 p.
 article
66 Animal model of Alzheimer's disease: Characteristic of avoidance learning of rat with entorhinal cortex lesion 1994
 15 S1 p. S16-
1 p.
 article
67 An in vivo system for studying the formation and reversal of neurofibrillary degeneration 1994
 15 S1 p. S34-
1 p.
 article
68 A non-classical action of acetylcholinesterase in the regulation of neurite outgrowth: Relevance to Alzheimer's disease 1994
 15 S1 p. S58-
1 p.
 article
69 A non-invasive peripheral nervous system test for Alzheimer's disease 1994
 15 S1 p. S92-
1 p.
 article
70 A Norwegian twin study of dementia shows genetic pattern in late-onset Alzheimer's disease 1994
 15 S1 p. S43-S44
2 p.
 article
71 A novel developmentally regulated protein, FAC1, is contained in plaques of the neocortex in Alzheimer's disease 1994
 15 S1 p. S122-
1 p.
 article
72 A novel polymorphism at codon 705 in the amyloid precursor protein (APP) gene found with single stranded conformation polymorphism (SSCP) analysis 1994
 15 S1 p. S131-
1 p.
 article
73 Antagonism of scopolamine-induced working memory impairments in rats by the cholinomimetic agents RU 35926 (CI-979) and RU 47213 1994
 15 S1 p. S103-
1 p.
 article
74 An update of ultrastructural model of paired helical filaments in Alzheimer disease 1994
 15 S1 p. S20-
1 p.
 article
75 APOE4 in clinically diagnosed Alzheimer's disease, frontal lobe degeneration and nondemented controls 1994
 15 S1 p. S132-
1 p.
 article
76 APOE peptide-induced neurite degeneration 1994
 15 S1 p. S118-
1 p.
 article
77 APO-E status and cognitive performance in normal controls and probable Alzheimer's patients 1994
 15 S1 p. S134-
1 p.
 article
78 Apolipoprotein ε-4 allotype prevalence is low in both normal and Alzheimer's disease oldest old subjects. The effect of selective survival? 1994
 15 S1 p. S73-
1 p.
 article
79 Apolipoprotein E4 affects neuropathology but not clinical progression in Alzheimer's disease 1994
 15 S1 p. S28-S29
2 p.
 article
80 Apolipoprotein E ϵ4 allele frequency in non-Alzheimer's dementias 1994
 15 S1 p. S44-
1 p.
 article
81 Apolipoprotein E-4 allele frequency in two different populations of patients with Alzheimer's disease 1994
 15 S1 p. S44-
1 p.
 article
82 Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease 1994
 15 S1 p. S131-S132
2 p.
 article
83 Apolipoprotein E allele ϵ4 in autopsy-confirmed Alzheimer's disease and cerebrovascular disease Altstiel, L.D.
 1994
 15 S1 p. S155-
1 p.
 article
84 Apolipoprotein E allele 4 is associated with dementia in the Framingham study 1994
 15 S1 p. S73-
1 p.
 article
85 Apolipoprotein E and Alzheimer disease 1994
 15 S1 p. S150-
1 p.
 article
86 Apolipoprotein E and beta amyloid (βA4) immunoreactive plaques in the aged monkey cortex 1994
 15 S1 p. S13-
1 p.
 article
87 Apolipoprotein E and early-onset familial Alzheimer disease: Lack of association and age-at-onset effect 1994
 15 S1 p. S154-
1 p.
 article
88 Apolipoprotein E and its receptor LRP in AD and control brain 1994
 15 S1 p. S117-
1 p.
 article
89 Apolipoprotein E and J immunoreactivity in Gerstmann-Sträussler-Scheinker disease Bugiani, O.
 1994
 15 S1 p. S156-S157
2 p.
 article
90 Apolipoprotein E and regional variation in diffuse plaques in Alzheimer's disease (AD) with and without Parkinson's disease (PD) changes: An immunohistochemical and molecular study 1994
 15 S1 p. S118-S119
2 p.
 article
91 Apolipoprotein E genotyping in Japanese patients with Alzheimer's disease and vascular dementia Kawamata, J.
 1994
 15 S1 p. S133-
1 p.
 article
92 Apolipoprotein-E immunoreactivity in amyloid deposits in Alzheimer's disease, but not in pathological aging or diffuse lewy body disease (DLBD) 1994
 15 S1 p. S138-
1 p.
 article
93 Apolipoprotein E isoform-specific interactions with cytoskeletal proteins 1994
 15 S1 p. S77-
1 p.
 article
94 Apolipoprotein E polymorphism in italian early onset familial and sporadic Alzheimer's disease Nacmias, B.
 1994
 15 S1 p. S132-
1 p.
 article
95 Apolipoprotein E type 2 allele decreases the risk of late-onset Alzheimer disease 1994
 15 S1 p. S72-S73
2 p.
 article
96 Apolipoprotein E type 4 allele lowers cerebral parietal metabolism in relatives at risk for familial Alzheimer disease 1994
 15 S1 p. S155-
1 p.
 article
97 Apoptotic cell death in Alzheimer's disease 1994
 15 S1 p. S30-S31
2 p.
 article
98 APP binds with high affinity to a specific heparan sulphate proteoglycan and stimulates neurite outgrowth 1994
 15 S1 p. S85-
1 p.
 article
99 β-APP751 transgenic mice exhibit impaired learning 1994
 15 S1 p. S12-
1 p.
 article
100 A prototype instrument for assessment of competency in AD 1994
 15 S1 p. S106-S107
2 p.
 article
101 A quantitative comparison of aluminum concentration in neurofibrillary tangles of Alzheimer's disease and parkinsonian dementia complex of Guam by laser microprobe mass analysis 1994
 15 S1 p. S28-
1 p.
 article
102 A questionnaire on the neuropathological diagnosis of Alzheimer disease in German-speaking countries: Consensus between practicing neuropathologists? Bancher, C.
 1994
 15 S1 p. S99-
1 p.
 article
103 Are severely-impaired Alzheimer's patients aware of their environment and illness? 1994
 15 S1 p. S105-S106
2 p.
 article
104 Arsenic treatment induces accumulation of proteins derived from amyloid precursor protein (APP) in rat liver and brain 1994
 15 S1 p. S66-
1 p.
 article
105 Assessment of cognitive speed in patients with mild Alzheimer's disease 1994
 15 S1 p. S92-
1 p.
 article
106 Association of cognitive functions with regional networks of brain metabolism in Alzheimer disease 1994
 15 S1 p. S36-
1 p.
 article
107 Association of tau to paired helical filaments 1994
 15 S1 p. S31-
1 p.
 article
108 Association study of apolipoprotein E and sporadic Alzheimer's disease in the Japanese population 1994
 15 S1 p. S132-S133
2 p.
 article
109 Astrocytes associated with senile plaques possess acetylcholine receptors 1994
 15 S1 p. S119-
1 p.
 article
110 A study of HPA axis function in Alzheimer's disease 1994
 15 S1 p. S94-
1 p.
 article
111 A trascriptional repressor of the interleukin-2 gene may also control APP gene expression 1994
 15 S1 p. S61-
1 p.
 article
112 Atrophy of the nucleus basalis meynerti complex (NBMC) in end-stage of Alzheimer's disease 1994
 15 S1 p. S111-
1 p.
 article
113 Attempt to purify the normal cellular isoform of prion protein from mouse and hamster brain 1994
 15 S1 p. S90-
1 p.
 article
114 Atypical dementia: Widening spectrum of prion diseases Gambetti, P.
 1994
 15 S1 p. S151-
1 p.
 article
115 Author index 1994
 15 S1 p. S161-S170
10 p.
 article
116 Beginnings and hopeful endings of Alzheimer research 1994
 15 S1 p. S5-
1 p.
 article
117 Behavioral changes in early Alzheimer's disease 1994
 15 S1 p. S35-
1 p.
 article
118 Behavioral rhythm abnormalities induced by β-amyloid protein 1994
 15 S1 p. S14-
1 p.
 article
119 Beta-amyloid induced metabolic changes in rat brain as revealed by proton nuclear magnetic resonance spectroscopy Caserta, M.
 1994
 15 S1 p. S14-
1 p.
 article
120 Beta-amyloid peptide is specifically recognized and cleaved by insulin-degrading enzyme Kurochkin, I.
 1994
 15 S1 p. S83-
1 p.
 article
121 Beyond β-protein—Role of lymphokines, amyloid promoting factors, and non-neuronal cells in the pathogenesis of Alzheimer's disease—Implications for diagnostics and therapy 1994
 15 S1 p. S70-
1 p.
 article
122 Binding studies of muscarinic cholinergic receptors in cultured adult skin fibroblasts Vestling, M.
 1994
 15 S1 p. S16-S17
2 p.
 article
123 Biochemical and structural analysis of paired helical filaments (PHF) in coticobasal degeneration 1994
 15 S1 p. S21-
1 p.
 article
124 Blood levels of histamine, interleukin-1β and tumor necrosis factor-α in Alzheimer's disease 1994
 15 S1 p. S93-
1 p.
 article
125 Brain aging in nonhuman primates: A similar process to humans? 1994
 15 S1 p. S13-
1 p.
 article
126 Brain electrical activity mapping correlates with cerebral blood flow velocity in Alzheimer's disease Franco-Maside, A.
 1994
 15 S1 p. S98-
1 p.
 article
127 Brain perfusion index (BPI) in Alzheimer's disease (AD): Evaluation of quantitative 99MTC-exametazime (HMPAO) rCBF index as an adjunct to scan appearance for ad diagnosis 1994
 15 S1 p. S96-
1 p.
 article
128 Brain tumor necrosis factor alpha (TNF) in Alzheimer's disease (AD) 1994
 15 S1 p. S153-
1 p.
 article
129 Buffy coat from sporadic and familial Alzheimer's disease patients induces abnormal neurofilament accumulation in hamster brain 1994
 15 S1 p. S34-S35
2 p.
 article
130 Cadmium chloride induces overexpression and altered processing of ßAPP in mammalian cell lines 1994
 15 S1 p. S17-
1 p.
 article
131 Caffeine enhances memory function after cholinergic blockade 1994
 15 S1 p. S100-S101
2 p.
 article
132 Calcineurin and PP-2A-induced dephosphorylation of tau protein and paired helical filaments 1994
 15 S1 p. S38-
1 p.
 article
133 Calcium influx or release increases amyloid β peptide production by transfected 293 cells 1994
 15 S1 p. S53-
1 p.
 article
134 Calmodulin as a candidate gene in early-onset chromosome 14-linked Alzheimer's disease 1994
 15 S1 p. S130-
1 p.
 article
135 Candidate genes for the major early-onset FAD locus on chromosome 14: Ascertainment and analysis 1994
 15 S1 p. S155-S156
2 p.
 article
136 Can interventions with family caregivers make a difference to them and to people with dementia? 1994
 15 S1 p. S3-
1 p.
 article
137 Carboxyl-terminal truncated APP is resistant to α- and β-secretase 1994
 15 S1 p. S51-
1 p.
 article
138 Cardiovascular safety and hormonal behaviour in demented elderly patients treated with posatirelin. Short term study 1994
 15 S1 p. S101-
1 p.
 article
139 Caregiving and the proliferation of stress 1994
 15 S1 p. S1-
1 p.
 article
140 Catabolism of amyloid precursor protein leads to beta-amyloid formation 1994
 15 S1 p. S51-
1 p.
 article
141 Cathepsin D: Activity and immunocytochemical localization in Alzheimer's disease (AD) and aging 1994
 15 S1 p. S57-
1 p.
 article
142 Cathepsin S generates Aβ peptides in transfected human cells and shows increased immunoreactivity in AD and DS brains 1994
 15 S1 p. S57-
1 p.
 article
143 Cause of death in Alzheimer's disease in Rochester, Minnesota 1994
 15 S1 p. S11-
1 p.
 article
144 Cell cycle dependent abnormal calcium response in fibroblasts from patients with familial Alzheimer's disease Tatebayashi, Y.
 1994
 15 S1 p. S87-
1 p.
 article
145 Cellular and tissue distribution of a zinc metalloprotease capable of generating potentially amyloidogenic fragments 1994
 15 S1 p. S56-
1 p.
 article
146 Cellular and transgenic mouse models to study senile plaque and β amyloid specific amyloidosis 1994
 15 S1 p. S30-
1 p.
 article
147 Cellular and ultracellular reactions to the intracerebral infusion of beta amyloid Maguire, J.
 1994
 15 S1 p. S80-S81
2 p.
 article
148 Cellular localization of α-secretase mediated proteolysis of APP 1994
 15 S1 p. S64-S65
2 p.
 article
149 Cellular processing of APP and production of Aβ 1994
 15 S1 p. S75-
1 p.
 article
150 Cellular processing of normal and mutant mammalian prion proteins 1994
 15 S1 p. S87-S88
2 p.
 article
151 Central serotonergic hyperresponsivity in Alzheimer's disease 1994
 15 S1 p. S101-
1 p.
 article
152 CERAD diagnosis of non-Alzheimer dementias: standardization and training 1994
 15 S1 p. S32-S33
2 p.
 article
153 Cerebral amyloid angiopathy (CAA) associated with progressive dementia without evidence of Alzheimer's changes at autopsy 1994
 15 S1 p. S112-
1 p.
 article
154 Cerebral metabolic ratio in Alzheimer's disease A positron emission tomographic study 1994
 15 S1 p. S97-S98
2 p.
 article
155 Characterization by radiosequencing of the carboxyl-terminal derivatives produced from normal and mutant amyloid β protein precursors 1994
 15 S1 p. S54-
1 p.
 article
156 Characterization of a monoclonal antibody raised against the extracellular domain of the amyloid precursor protein which recognizes tau proteins Philippe, B.
 1994
 15 S1 p. S86-
1 p.
 article
157 Characterization of monoclonal antibodies raised against human entorhinal cortex using the sofistic hybridoma technique 1994
 15 S1 p. S27-S28
2 p.
 article
158 Characterization of neuropsychological function in Alzheimer's patients with prominent visual impairments 1994
 15 S1 p. S36-
1 p.
 article
159 Characterization of the promoter of the mouse amyloid precursor protein homologue, APLP2 von Koch, C.S.
 1994
 15 S1 p. S86-
1 p.
 article
160 Charting the caregiving career: A unified framework for interpreting informal caregiving processes and outcomes 1994
 15 S1 p. S1-
1 p.
 article
161 Chondroitin sulfate proteoglycan form of Alzheimer's amyloid precursor protein is produced mostly in astrocytes but not in neurons 1994
 15 S1 p. S83-S84
2 p.
 article
162 Chronic low dose eptastigmine in Alzheimer patients: Relationship between acetylcholinesterase inhibition and cognitive effects 1994
 15 S1 p. S100-
1 p.
 article
163 Clinical and genealogic study of a new familial Alzheimer's disease (FAD) 1994
 15 S1 p. S128-S129
2 p.
 article
164 Clinical and genetic comparison between two FAD families with the same geographic origin 1994
 15 S1 p. S130-
1 p.
 article
165 Clinical and neurophysiological evaluation of 3 doses of S120242 (50, 100, 200 mg o.d.) during repeated oral administration (7 days) in 12 out-patients with mild to moderate Alzheimer's disease Derouesné, C.
 1994
 15 S1 p. S100-
1 p.
 article
166 Clinical assessment of quality of life in Alzheimer disease : An assessment of current rating scales Hugonot-Diener, L.
 1994
 15 S1 p. S135-S136
2 p.
 article
167 Clinical characteristics of African-American outpatients with Alzheimer's disease 1994
 15 S1 p. S8-
1 p.
 article
168 Clinical development of a muscarinic agonist: CI-979/RU 35926 1994
 15 S1 p. S148-
1 p.
 article
169 Clinical features of Alzheimer's disease with brainstem Lewy bodies and nigral degeneration 1994
 15 S1 p. S98-
1 p.
 article
170 Clinical heterogeneity in familial Alzheimer's disease 1994
 15 S1 p. S140-
1 p.
 article
171 Clinical pathological correlations in 290 consecutive autopsies in patients with dementia 1994
 15 S1 p. S110-
1 p.
 article
172 Clinical phenotype of chromosome 14q24 associated FAD in the Italian-American (Feldman FAD Family) pedigree Gaston, S.M.
 1994
 15 S1 p. S9-
1 p.
 article
173 Clinicopathologic correlations of soluble amyloid β-protein precursor in cerebrospinal fluid from Alzheimer's disease patients and age-matched controls 1994
 15 S1 p. S146-
1 p.
 article
174 Codon 200 mutation in a new Creutzfeldt-Jakob disease family of Chilean origin Salvatore, M.
 1994
 15 S1 p. S88-
1 p.
 article
175 Cognition-independent neurologic markers of the course of Alzheimer's disease (AD) 1994
 15 S1 p. S7-
1 p.
 article
176 Cognitive and non cognitive profiles in cerebrovascular disorders and senile dementia: A neuropsychological study 1994
 15 S1 p. S106-
1 p.
 article
177 Cognitive, brain atrophy and socio-medical correlates of hippocampal atrophy in an open population of old persons 1994
 15 S1 p. S47-
1 p.
 article
178 Cognitive functions of family members with and without the APP 670/671 mutation 1994
 15 S1 p. S29-
1 p.
 article
179 Cognitive performance in elderly care institutions in Sweden 1994
 15 S1 p. S136-
1 p.
 article
180 Cognitive performance test: A new approach to functional assessment in Alzheimer's disease 1994
 15 S1 p. S135-
1 p.
 article
181 Combination of tacrine and selegiline in Alzheimer's disease: An open pilot study 1994
 15 S1 p. S136-
1 p.
 article
182 Community screening for dementia in Indianapolis and Ibadan, Nigeria 1994
 15 S1 p. S42-
1 p.
 article
183 Comparison of clinical features, neuropathology, and intracerebral distribution of PRP amyloid protein in the brains of patients with spongiform encephalopathy 1994
 15 S1 p. S150-
1 p.
 article
184 Conformational pathways of scrapie amyloid (prion) protein and the structure-function relationship with infectivity 1994
 15 S1 p. S157-S158
2 p.
 article
185 Conformation and fibrillogenesis of Alzheimer Aβ peptides with selected substitution of charged residues 1994
 15 S1 p. S80-
1 p.
 article
186 Confounding with genes may explain the inverse association of smoking and Alzheimer's disease 1994
 15 S1 p. S128-
1 p.
 article
187 Confounding with genes may explain the inverse association of smoking and Alzheimer's disease 1994
 15 S1 p. S150-
1 p.
 article
188 Construction of a STS based YAC contig map of the early-onset Alzheimer's disease region on chromosome 14Q24.3 1994
 15 S1 p. S129-S130
2 p.
 article
189 Contributions of phosphorylation and metal-binding to in vitro assembly of alzheimer paired helical filaments 1994
 15 S1 p. S78-
1 p.
 article
190 Correlations between neuropsychological and neuropathological data in Alzheimer's disease 1994
 15 S1 p. S110-
1 p.
 article
191 Cortical tau protein and neurofibrillary tangles in lewy body dementia, Alzheimer's disease, Parkinson's disease and controls 1994
 15 S1 p. S22-
1 p.
 article
192 Cortical visual impairment in Alzheimer disease (AD): A positron emission tomography (PET) study of resting cerebral glucose metabolism 1994
 15 S1 p. S36-
1 p.
 article
193 Cortico-limbic abnormalities in transgenic mice expressing amyloid precursor proteins 1994
 15 S1 p. S76-
1 p.
 article
194 Cos cells overexpressing the LDL-receptor take up Apo E from fresh cerebrospinal fluid 1994
 15 S1 p. S16-
1 p.
 article
195 Course and treatment of Alzheimer's disease Sclan, S.G.
 1994
 15 S1 p. S6-
1 p.
 article
196 Criteria for diagnosis of pure Alzheimer's disease 1994
 15 S1 p. S90-
1 p.
 article
197 Cross-cultural validation of the mini-mental state examination (MMSE) and of the pfeffer functional activities questionnaire (PFAQ) 1994
 15 S1 p. S68-
1 p.
 article
198 CSF concentrations of CRF in Alzheimer's disease and normal pressure hydrocephalus 1994
 15 S1 p. S121-
1 p.
 article
199 Culture of canine vascular myocytes as a model to study production and accumulation of β-protein by cells involved in amyloidogenesis∗ 1994
 15 S1 p. S142-
1 p.
 article
200 Cytokines, prostaglandins and lipocortin-1 are present in the brains of scrapie-infected mice 1994
 15 S1 p. S89-
1 p.
 article
201 Cytoskeletal transformations in dystrophic neurites of senile plaques 1994
 15 S1 p. S23-
1 p.
 article
202 Decreased apolipoprotein-E concentrations in cerebrospinal fluid (CSF) correlate with decreased beta-amyloid protein concentrations in CSF from patients with Alzheimer's disease (AD) 1994
 15 S1 p. S59-
1 p.
 article
203 Defective PKCα regulation in skin fibroblasts from Alzheimer's disease patients 1994
 15 S1 p. S72-
1 p.
 article
204 Dementia diagnosis in primary care: Results of a representative survey in Southern Lower Saxony, Germany 1994
 15 S1 p. S90-
1 p.
 article
205 Dementia in the elderly alcoholic — A retrospective clinicopathological study 1994
 15 S1 p. S8-S9
2 p.
 article
206 Dementia with frontal lobe features: A pathological and positron emission tomography study Freo, U.
 1994
 15 S1 p. S10-
1 p.
 article
207 Dephosphorylation of Alzheimer disease abnormally phosphorylated tau by protein phosphatase-2A 1994
 15 S1 p. S37-S38
2 p.
 article
208 Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase 2A and 2B 1994
 15 S1 p. S23-
1 p.
 article
209 Derivation of a temperature-sensitive hippocampal precursor cell line and transplantation into the newborn mouse brain Babbey, L.E.
 1994
 15 S1 p. S17-
1 p.
 article
210 Desensitization of the neuronal insulin receptor as an etiological factor in sporadic late-onset dementia of the Alzheimer type (SDAT)? 1994
 15 S1 p. S139-
1 p.
 article
211 Detection and characterization of a cellular protein which binds to the cytoplasmic domain of APP 1994
 15 S1 p. S85-S86
2 p.
 article
212 Detection of a novel CDC2-related kinase in Alzheimer paired helical filaments 1994
 15 S1 p. S24-
1 p.
 article
213 Detection of phosphorylated tau in cerebrospinal fluid 1994
 15 S1 p. S94-
1 p.
 article
214 Detection of subjects with a high risk of developing dementia is a major issue of epidemiological research. Among the potential predictors, minor cognitive impairments detected by psychometric could be the best candidates 1994
 15 S1 p. S68-
1 p.
 article
215 Detection of tau in cerebrospinal fluid 1994
 15 S1 p. S145-S146
2 p.
 article
216 Developmental and age-related changes in the levels of β-amyloid and β-amyloid precursor protein in human cerebrospinal fluid 1994
 15 S1 p. S158-
1 p.
 article
217 Development of a model system for Alzheimer's disease involving aluminium 1994
 15 S1 p. S19-
1 p.
 article
218 Development of antibody probes to discriminate the C-terminus of Aβ 1994
 15 S1 p. S54-
1 p.
 article
219 Diagnosis and incidence of prion (creutzfeldt-jakob) disease: a retrospective archival survey 1994
 15 S1 p. S156-
1 p.
 article
220 Diagnosis and stageing of Alzheimer's disease in a prospective study involving aged individuals 1994
 15 S1 p. S140-S141
2 p.
 article
221 Diagnosis of Alzheimer's disease: Development of cytoskeletal changes and staging of Alzheimer related intraneuronal pathology 1994
 15 S1 p. S141-
1 p.
 article
222 Diet patterns during adult life in a case control study of risk factors for Alzheimer's disease: preliminary data for selected nutrients and food groups 1994
 15 S1 p. S47-
1 p.
 article
223 Differences in verbal memory impairment in Alzheimer's disease and frontal lobe type dementia 1994
 15 S1 p. S91-
1 p.
 article
224 Different cognitive impairment in subjects with age-associated memory impairment and in subgroups of Alzheimer's disease patients 1994
 15 S1 p. S91-S92
2 p.
 article
225 Differential affinity binding of vascular cell proteoglycans to the Aβ of Alzheimer's disease 1994
 15 S1 p. S57-
1 p.
 article
226 Differential effects of β-amyloid peptides on radioligand binding to the NMDA receptor complex Cowburn, Richard F.
 1994
 15 S1 p. S18-
1 p.
 article
227 Differential effects of hAPP695 and hAPP751 in a transgenic model of neurodegeneration 1994
 15 S1 p. S33-S34
2 p.
 article
228 Different proliferation kinetic and response to growth factors of familial Alzheimer disease fibroblasts 1994
 15 S1 p. S58-
1 p.
 article
229 Direct evidence of defects in mitochondrial electrochemical gradient- and PKC- activity in human skin fibroblasts and lymphocytes of sporadic and familial AD patients 1994
 15 S1 p. S71-S72
2 p.
 article
230 Disease progression correlates with decreasing CSF β-amyloid in alzheimer patients with the swedish APP 670/671 mutation 1994
 15 S1 p. S79-
1 p.
 article
231 Distribution and development of plaque formations in beagles 1994
 15 S1 p. S33-
1 p.
 article
232 Distribution of amyloid deposits and senile plaques within the hippocampal and parahippocampal formation of patients with down syndrome 1994
 15 S1 p. S112-
1 p.
 article
233 Distribution of phosphorylated neurofilament in Alzheimer's disease 1994
 15 S1 p. S27-
1 p.
 article
234 Distribution of the iron-binding protein lactotransferrin in the pathological lesions of a variety of neurodegenerative diseases 1994
 15 S1 p. S126-
1 p.
 article
235 DNA damage and repair in Alzheimer's disease lymphocytes 1994
 15 S1 p. S121-
1 p.
 article
236 DNA sequence of the cystatin C gene on a Japanese amyloid angiopathy patient 1994
 15 S1 p. S129-
1 p.
 article
237 Does smoking protect from Alzheimer's disease? An epidemiological study based on neuropathology 1994
 15 S1 p. S46-
1 p.
 article
238 Dose determination strategies in the development of acetylcholinesterase inhibitors 1994
 15 S1 p. S148-
1 p.
 article
239 Drug development must be optimized in order to choose the correct strategy 1994
 15 S1 p. S148-
1 p.
 article
240 Dynamic changes in aggregation state of amyloid-β peptide (AB) correlate with altered neurotoxic properties 1994
 15 S1 p. S18-
1 p.
 article
241 Dynein associated polypeptides are increased in PC12 cells cultured in NGF or Alzheimer's disease brain extracts 1994
 15 S1 p. S38-S39
2 p.
 article
242 Early clinical manifestations and the course of Alzheimer's disease related to regional cerebral blood flow (rCBF) and neuropathology 1994
 15 S1 p. S5-
1 p.
 article
243 Education and socio-economic status as risk factors for dementia: Data from the Canadian study of health and aging 1994
 15 S1 p. S40-
1 p.
 article
244 EEG profiles in the members of a chromosome 14 linked family and the family with an APP 670/671 mutation 1994
 15 S1 p. S9-S10
2 p.
 article
245 Effect of iron on aluminum chloride uptake in rabbits 1994
 15 S1 p. S20-
1 p.
 article
246 Effect of long-term adrenalectomy on hippocampal neurons and cognitive behaviour Adem, Abdu
 1994
 15 S1 p. S15-S16
2 p.
 article
247 Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of full length amyloid peptides Clements, A.
 1994
 15 S1 p. S48-S49
2 p.
 article
248 Effects of the mutations Glu22 to Gln and Ala21 to Gly on zinc binding to the Aβ peptide Walsh, D.M.
 1994
 15 S1 p. S48-
1 p.
 article
249 Effects of two different immunotropic drugs in experimental therapy of Alzheimer's disease patients Leszek, J.
 1994
 15 S1 p. S137-
1 p.
 article
250 Efficacy and safety of sabeluzole in patients with probable Alzheimer's disease Nair, N.P.V.
 1994
 15 S1 p. S137-
1 p.
 article
251 Elevated levels of cathepsin D in cerebrospinal fluid from Alzheimer disease patients 1994
 15 S1 p. S115-
1 p.
 article
252 Endocytic targeting of a cellular prion protein 1994
 15 S1 p. S157-
1 p.
 article
253 Endosomal-lysosomal system abnormalities: an early marker of neuronal dysfunction in Alzheimer disease 1994
 15 S1 p. S32-
1 p.
 article
254 Enhanced expression of amyloid precursor protein and protein kinase Cα following neuronal injury 1994
 15 S1 p. S61-
1 p.
 article
255 Enhanced neuroplasticity by sabeluzole: An overview of the available in vivo evidence Clincke, G.H.C.
 1994
 15 S1 p. S15-
1 p.
 article
256 Environmentally induced changes in hippocampal glucocorticoid receptors and NGF levels: Implications for the aging rat Henriksson, B.G.
 1994
 15 S1 p. S14-
1 p.
 article
257 Estimating premorbid intelligence in demented patients using neuropsychological instruments 1994
 15 S1 p. S8-
1 p.
 article
258 Estimation of the sensitivity and specificity of a dementia screening test in a population-based survey 1994
 15 S1 p. S42-
1 p.
 article
259 Estrogen replacement therapy and cognitive performance in postmenopausal Japanese-American women: the KAME project 1994
 15 S1 p. S44-
1 p.
 article
260 Etiologic classification of clinical diagnosis among patients reported to the New York State dementia registry 1994
 15 S1 p. S41-S42
2 p.
 article
261 Evaluation of a modified version of the cognitive abilities screening instrument (CASI) for assessment of dementia in elderly chamorros on Guam 1994
 15 S1 p. S43-
1 p.
 article
262 Evaluation of brain element composition in Alzheimer's disease using inductively-coupled plasma mass spectrometry 1994
 15 S1 p. S113-
1 p.
 article
263 Evidence for neuronal and non-neuronal origin of β-protein and slow fibrillization thioflavin S-negative plaques Wisniewski, H.M.
 1994
 15 S1 p. S5-
1 p.
 article
264 Evidence that secretory processing of cell surface Alzheimer's amyloid precursor protein requires endocytosis 1994
 15 S1 p. S64-
1 p.
 article
265 Exchangeable apolipoproteins expression in the brain and the neuropathology of AD 1994
 15 S1 p. S117-S118
2 p.
 article
266 Experimental trophic therapy. Protection of cholinergic phenotype and cortical synaptic remodelling Claudio Cuello, A.
 1994
 15 S1 p. S82-
1 p.
 article
267 Expression and analysis of human clusterin (Apo J) protein from a stably transfected mammalian cell line 1994
 15 S1 p. S56-
1 p.
 article
268 Expression and metabolism of mutant human Aβ-amyloid precursor protein (APP) in transgenic mice and cultured cells 1994
 15 S1 p. S71-
1 p.
 article
269 Expression of a late differentiation macrophage marker indicates an enhanced lysosomal activity of microglial cells in senile plaques 1994
 15 S1 p. S115-
1 p.
 article
270 Expression of APP mRNA lacking exon 15 is lower in the brain than in non-neural tissues 1994
 15 S1 p. S61-
1 p.
 article
271 Expression of interleukin one and six receptors following cortical ischaemia: Possible relevance to Alzheimer's disease 1994
 15 S1 p. S122-
1 p.
 article
272 Expression of protein phosphatases PP-1, PP-2A, PP-2B and PTP-1B and protein kinases map kinase and P34cdc2 in the hippocampus of patients with Alzheimer disease and normal aged individuals 1994
 15 S1 p. S113-
1 p.
 article
273 Expression of the Alzheimer amyloid-promoting factors α1-antichymotrypsin and apolipoprotein E is induced in astrocytes by IL-1 1994
 15 S1 p. S17-
1 p.
 article
274 Factors associated with cognitive impairment in an italian nursing home population 1994
 15 S1 p. S135-
1 p.
 article
275 Familial Alzheimer's disease, description of a pedigree segregating the APP 670/671 mutation 1994
 15 S1 p. S9-
1 p.
 article
276 Familial progressive leukoencephalopathy of adult onset 1994
 15 S1 p. S111-
1 p.
 article
277 Family studies of APOE in early and late onset Alzheimer disease 1994
 15 S1 p. S131-
1 p.
 article
278 Family with 22-derived marker chromosome and dementia of the Alzheimer type: An update 1994
 15 S1 p. S127-
1 p.
 article
279 FGF-2 and IL-1β regulate S-100β mRNA levels in rat cerebral cortical astrocyte cultures 1994
 15 S1 p. S131-
1 p.
 article
280 Fibrillar and non-fibrillar amyloid in the brain of aged dogs 1994
 15 S1 p. S29-S30
2 p.
 article
281 Frequency of Apolipoprotein E alleles in various forms of dementia 1994
 15 S1 p. S133-S134
2 p.
 article
282 Frontal degenerative dementia 1994
 15 S1 p. S144-
1 p.
 article
283 Functional alterations in Alzheimer's disease: selective loss of mitochondrial encoded cytochrome oxidase mRNA in the hippocampal formation 1994
 15 S1 p. S125-
1 p.
 article
284 Functional analysis of the rat amyloid precursor protein (APP) gene promoter 1994
 15 S1 p. S61-
1 p.
 article
285 Functional assessment and care plans: The interface between problem identification and treatment 1994
 15 S1 p. S4-
1 p.
 article
286 Further analysis of the brain Na+/Ca2+ exchanger in Alzheimer's disease 1994
 15 S1 p. S142-S143
2 p.
 article
287 Gangliosides and Alzheimer type dementia 1994
 15 S1 p. S29-
1 p.
 article
288 Generation of amyloidogenic and non-amyloidogenic C-terminal fragments during rapid axonal transport of APP in vivo 1994
 15 S1 p. S66-
1 p.
 article
289 Genesis and degradation of Aβ protein by cultured human neuroblastoma cells 1994
 15 S1 p. S159-
1 p.
 article
290 Genetic epidemiological studies of APOE and Alzheimer disease 1994
 15 S1 p. S132-
1 p.
 article
291 Genetic heterogeneity & environmental interaction in the association between Alzheimer's disease and apolipoprotein-E 1994
 15 S1 p. S73-
1 p.
 article
292 Genetics of Alzheimer's disease 1994
 15 S1 p. S109-
1 p.
 article
293 Genetics of Alzheimer's disease: APP, APOE, and the chromosome 14 locus Hardy, John
 1994
 15 S1 p. S126-
1 p.
 article
294 Genetic studies of CHR 14 in early onset FAD 1994
 15 S1 p. S149-
1 p.
 article
295 Genomic screen to identify additional Alzheimer disease effects in late onset disease 1994
 15 S1 p. S134-
1 p.
 article
296 Geographical distribution of Alzheimer's disease neuropathological phenotypes in a region of Quebec/Canada (Image Project) 1994
 15 S1 p. S41-
1 p.
 article
297 Gerstmann-Straussler-Scheinker disease: Genealogical, anatomical and immunohistochemistry studies of a French family 1994
 15 S1 p. S89-
1 p.
 article
298 Gerstmann-Sträussler-Scheinker disease (GSS) 1994
 15 S1 p. S151-
1 p.
 article
299 Glial reaction in the cerebral cortex and spinal cord in cases of “non-respiratory” amyotrophic lateral sclerosis (ALS) 1994
 15 S1 p. S119-
1 p.
 article
300 Glutamate, colchicine and β-amyloid induce dephosphorylation of the microtubule associated protein tau and a change in perikaryal tau-immunoreactivity in rat cortical neurones in primary culture Davis, D.R.
 1994
 15 S1 p. S25-
1 p.
 article
301 Glutamate enhances tau mRNA expression in primary neuronal cultures 1994
 15 S1 p. S26-
1 p.
 article
302 Glycation increases the permeability of proteins across the blood nerve and blood brain barriers 1994
 15 S1 p. S18-S19
2 p.
 article
303 Growth properties of skin fibroblasts from centenarians 1994
 15 S1 p. S12-S13
2 p.
 article
304 Haloperidol treatment of behavioral disturbances in alzheimer patients 1994
 15 S1 p. S81-S82
2 p.
 article
305 Head size as a risk factor for cognitive impairment in elderly Japanese-Americans: The Kame project 1994
 15 S1 p. S74-
1 p.
 article
306 Helping families of persons with dementia 1994
 15 S1 p. S2-
1 p.
 article
307 Hemodynamic parameters of the middle cerebral artery in cerebrovascular disorders and senile dementia: A transcranial Doppler study 1994
 15 S1 p. S96-
1 p.
 article
308 Heparin increases the secretion of β-secretase derived APP derivatives in neuroblastoma cells 1994
 15 S1 p. S62-
1 p.
 article
309 Heterogeneity in dementia of the Alzheimer type as demonstrated by SPECT-HMPAO brain imaging 1994
 15 S1 p. S97-
1 p.
 article
310 Heterogeneity of Alzheimer's disease (AD): Prognostic value of plateau phases 1994
 15 S1 p. S8-
1 p.
 article
311 Heterogeneity of cortical nicotinic receptors and differential changes in Alzheimer's disease Whitehouse, P.J.
 1994
 15 S1 p. S153-
1 p.
 article
312 High level expression of the C-terminal end of the β-amyloid precursor protein in E. coli 1994
 15 S1 p. S60-
1 p.
 article
313 Hippocampal sclerosis secondary to vascular insufficiency as a cause of Alzheimer-like dementia Robitaille, Y.
 1994
 15 S1 p. S111-
1 p.
 article
314 Hippocampal sclerosis with Alzheimer pathology in elderly subjects with amnesia but not dementia 1994
 15 S1 p. S98-
1 p.
 article
315 Histamine, interleukin-1β and tumor necrosis factor-α correlate with brain electrical activity mapping in Alzheimer's disease 1994
 15 S1 p. S121-
1 p.
 article
316 Histone H4 binds to secreted APP and is toxic to the human monocytic cell line U937 1994
 15 S1 p. S85-
1 p.
 article
317 24 hour cortisol circadian rhythm in Alzheimer's disease: Comparison with normal subjects Rosenberg, C.E.
 1994
 15 S1 p. S10-
1 p.
 article
318 Identification of divalent ions as modulating factors for the function of the βA4 amyloid protein precursor 1994
 15 S1 p. S142-
1 p.
 article
319 Identification of plaque cofactors in non-demented and ad brain 1994
 15 S1 p. S52-
1 p.
 article
320 Identification of proteins interacting with the cytoplasmic domain of the amyloid precursor protein 1994
 15 S1 p. S159-
1 p.
 article
321 Identification of the basement membrane protein binding sites on the Alzheimer's β precursor protein 1994
 15 S1 p. S84-
1 p.
 article
322 Immortalisation of Hippocampus and Neocortex cells from the Trisomy 16 mouse 1994
 15 S1 p. S11-
1 p.
 article
323 Immunocytochemical and genotypic polymorphism of apolipoprotein E in senile dementias of the AD and non-AD types Robitaille, Y.
 1994
 15 S1 p. S117-
1 p.
 article
324 Immunohistochemical evidence that Aβ1–42 is more abundant in amyloid plaques than Aβ1–40 in Alzheimer's disease brain 1994
 15 S1 p. S52-S53
2 p.
 article
325 Immunohistochemical localization of a zinc metalloprotease capable of degrading the amyloid precursor protein 1994
 15 S1 p. S56-
1 p.
 article
326 Immunological aspects of dementias-serum cytokines and immunoglobulines Tsolaki, M.
 1994
 15 S1 p. S93-
1 p.
 article
327 Immunological mechanisms and functional state of the blood-brain barrier in the pathogenesis of Alzheimer disease 1994
 15 S1 p. S121-
1 p.
 article
328 Immunoreactivity of complement components and GFAP within Alzheimer and pathologic aged cortex 1994
 15 S1 p. S124-
1 p.
 article
329 Immunoreactivity to apolipoprotein E, J and ubiquitin in diffuse β amyloid deposits in various brain areas in Alzheimer's disease and down's syndrome cases 1994
 15 S1 p. S119-
1 p.
 article
330 Immunoreactivity to ubiquitin-activating enzyme (E1) of neurofibrillary tangles in Alzheimer's disease 1994
 15 S1 p. S114-S115
2 p.
 article
331 Impairment in gene expression of oxidative metabolism in vulnerable brain regions in Alzheimer disease 1994
 15 S1 p. S125-
1 p.
 article
332 Incidence of dementia and probable Alzheimer's disease in a general elderly population: The pamplona study 1994
 15 S1 p. S40-S41
2 p.
 article
333 Incidence of different types of dementia disorders in a large consecutive autopsy series 1994
 15 S1 p. S140-
1 p.
 article
334 Increased activity of monoamine oxidase-B in plaque-associated astrocytes in Alzheimer brain demonstrated by quantitative enzyme autoradiography using 3H-lazabemide Saura, J.
 1994
 15 S1 p. S120-S121
2 p.
 article
335 Increased cathepsin D immunoreactivity in inferior olivary neurons in Alzheimer's disease 1994
 15 S1 p. S57-
1 p.
 article
336 Increased density of cortical senile plaques (SP) in non-demented individuals with the apolipoprotein-E4 genotype 1994
 15 S1 p. S144-S145
2 p.
 article
337 Increased expression of S100β in brain of IM mice injected with 87V scrapie strain 1994
 15 S1 p. S89-
1 p.
 article
338 Increased lipid peroxidation and antioxidant enzyme activity in the brain in Alzheimer's disease 1994
 15 S1 p. S139-S140
2 p.
 article
339 Increased proteolytic activity in erythrocytes and lymphocytes from patients with Alzheimers disease 1994
 15 S1 p. S93-
1 p.
 article
340 Increased risk of Alzheimer's disease among mothers of adults with down syndrome 1994
 15 S1 p. S73-S74
2 p.
 article
341 Increased tau levels in the cerebrospinal fluid in carriers of the Swedish 670/671 mutation in the amyloid precursor protein 1994
 15 S1 p. S146-
1 p.
 article
342 Increasing of interleukin-1 production may speed up the course of dementia of alzheimer's type 1994
 15 S1 p. S50-
1 p.
 article
343 Indo-US cross national dementia epidemiology study: Rationale, methods, effect of education on cognitive screening 1994
 15 S1 p. S74-S75
2 p.
 article
344 Induction of interleukin-1β converting enzyme by lipopolysaccharide in mouse microglia 1994
 15 S1 p. S122-
1 p.
 article
345 Induction of signal tranducing pathways by APP binding to the cell surface receptor 1994
 15 S1 p. S159-
1 p.
 article
346 Inflammatory cytokine secretion from human astrocytoma cells: Conformation- and Ca2+-dependent effects of amyloidogenic peptides 1994
 15 S1 p. S123-S124
2 p.
 article
347 Influence of serum cholesterol, smoking status, and apolipoprotein E phenotype on cognitive function in older Japanese-American men 1994
 15 S1 p. S44-S45
2 p.
 article
348 Inhibition of neuritic outgrowth in a mouse motoneuron cell line by immobilized Aβ amyloid fibres 1994
 15 S1 p. S115-
1 p.
 article
349 Inhibition of toxic desferrioxamine metabolism by isoniazid 1994
 15 S1 p. S103-S104
2 p.
 article
350 In-home family caregiver training: Targeting african americans 1994
 15 S1 p. S2-
1 p.
 article
351 Insertion of pathogenic mutations into APP-containing YACS 1994
 15 S1 p. S70-S71
2 p.
 article
352 Insulin-like growth factors in cerebrospinal fluid and serum of patients with Alzheimer's disease and Parkinson's disease 1994
 15 S1 p. S10-S11
2 p.
 article
353 Interaction between βPP and tau: A possible link between β-amyloid and NFT formation 1994
 15 S1 p. S77-S78
2 p.
 article
354 Interaction of microglia with extracellular matrix modulates APP biogenesis 1994
 15 S1 p. S62-
1 p.
 article
355 Interleukin-1β alters amyloid precursor protein expression and processing in H4 neuroglioma cells 1994
 15 S1 p. S62-
1 p.
 article
356 Intracellular transport of β-amyloid precursor protein in polarized and non-polarized cells 1994
 15 S1 p. S63-
1 p.
 article
357 Intrachain and interchain complexes of neurofilament peptides: A link between AL3+ and Alzheimer's disease 1994
 15 S1 p. S72-
1 p.
 article
358 Intranasal delivery of 125I-NGF to the brain via the olfactory route 1994
 15 S1 p. S137-S138
2 p.
 article
359 Introduction Coleman, Paul D.
 1994
 15 S1 p. v-
1 p.
 article
360 Introduction of yeast artificial chromosomes containing normal and mutant amyloid precursor protein genes into transgenic mice 1994
 15 S1 p. S12-
1 p.
 article
361 Investigation of the function(s) of the microtubule associated protein tau 1994
 15 S1 p. S24-
1 p.
 article
362 In vivo microtubule binding capacity of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament Fasulo, L.
 1994
 15 S1 p. S21-
1 p.
 article
363 Involvement of clathrin light chains in pathology of Alzheimer's disease and pick' S disease: implication for impairment of axonal transport 1994
 15 S1 p. S27-
1 p.
 article
364 Is Alzheimer's disease caused by impaired delivery of energy substrates to the brain? 1994
 15 S1 p. S152-S153
2 p.
 article
365 Is APP an autoantigen? Peptides corresponding to parts of the APP sequence stimulate T lymphocytes in normals, but not in patients with Alzheimer's disease 1994
 15 S1 p. S87-
1 p.
 article
366 Is head injury a risk factor for Alzheimer's disease? Graham, D.I.
 1994
 15 S1 p. S116-
1 p.
 article
367 Is improvement of cholinergic transmission the correct strategy for Alzheimer's disease? Bowen, D.M.
 1994
 15 S1 p. S147-
1 p.
 article
368 Issues in molecular genetic diagnostic testing in early-onset familial Alzheimer's disease, with an illustrative case vignette 1994
 15 S1 p. S95-S96
2 p.
 article
369 Is there disfunction of the brain cholinergic systems in the relatives of the patients with the Alzheimer's disease? 1994
 15 S1 p. S127-
1 p.
 article
370 7 KD amyloid subunit in GSS disease (Indiana and Swedish kindreds) contains only PRP peptides derived from the mutant allele 1994
 15 S1 p. S143-
1 p.
 article
371 Lack of association between apolipoprotein E allele e 4 and sporadic Alzheimer's disease 1994
 15 S1 p. S154-
1 p.
 article
372 Lack of relationship between Alz-50 staining, B-A4 accumulation and neuronal activity in the human hypothalamus of Alzheimer patients 1994
 15 S1 p. S138-S139
2 p.
 article
373 Lack of topographical relationship between sites of aluminum deposition and plaques and tangles in the different areas of Alzheimer's disease brain samples Kasa, P.
 1994
 15 S1 p. S125-S126
2 p.
 article
374 Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease (AD) and control brains 1994
 15 S1 p. S21-S22
2 p.
 article
375 Linkage analysis of early-onset Alzheimer's disease in the Japanese population 1994
 15 S1 p. S130-
1 p.
 article
376 Localization of a new ferritin heavy chain sequence present in human brain mRNA to chromosome II 1994
 15 S1 p. S127-S128
2 p.
 article
377 Longitudinal pet studies in families with chromosome 14 and 21 encoded Alzheimer's disease 1994
 15 S1 p. S147-
1 p.
 article
378 Long-term, double-blind trial of selegiline in Alzheimer's disease 1994
 15 S1 p. S67-
1 p.
 article
379 Long-term treatment with selegiline decreases the CSF concentration of amyloid precursor protein in patients with Alzheimer's disease 1994
 15 S1 p. S59-
1 p.
 article
380 Long-term treatment with tacrine delays progression of Alzheimer's disease as determined by cognitive tests, EEG and PET 1994
 15 S1 p. S81-
1 p.
 article
381 Loss of cortical cholinergic fibers in Alzheimer's disease: Lack of a relationship with amyloid deposits but a modest relationship with tangle density 1994
 15 S1 p. S120-
1 p.
 article
382 Loss of neurofilament epitopes from axons of Lewy body-containing neurons 1994
 15 S1 p. S114-
1 p.
 article
383 Loss of paroxetine binding in the neocortex is associated with depression in Alzheimer's disease 1994
 15 S1 p. S36-S37
2 p.
 article
384 Low-density lipoprotein pathways in primary cultures of rat astrocytes and effect of apolipoprotein E genotype 1994
 15 S1 p. S155-
1 p.
 article
385 Low education, dementia and brain reserve 1994
 15 S1 p. S68-
1 p.
 article
386 Macromolecular permeability across the blood nerve and blood brain barriers 1994
 15 S1 p. S34-
1 p.
 article
387 Managing problem behaviors associated with Alzheimer's disease: A piagetian approach 1994
 15 S1 p. S101-S102
2 p.
 article
388 Maternal and paternal age differences between Alzheimer's cases and controls 1994
 15 S1 p. S46-
1 p.
 article
389 Measurement of function and quality of life in Alzheimer's patients 1994
 15 S1 p. S135-
1 p.
 article
390 Measurement of tau in human CSF and its possible utility in Alzheimer's disease diagnosis 1994
 15 S1 p. S95-
1 p.
 article
391 Measures of temporal lobe atrophy in probable Alzheimer's disease 1994
 15 S1 p. S96-
1 p.
 article
392 Mechanism of cerebral amyloidogenesis in Alzheimer's disease Allsop, D.
 1994
 15 S1 p. S69-
1 p.
 article
393 Mechanisms of cerebral amyloid angiopathy (CAA) in Alzheimer's Disease: Soluble Aβ protein in brain vessels 1994
 15 S1 p. S51-S52
2 p.
 article
394 Memory impairment after hyperventilation — A physiological model of cognitive dysfunctions Rother, M.
 1994
 15 S1 p. S92-
1 p.
 article
395 Metabolism of APP in vascular myocytes 1994
 15 S1 p. S52-
1 p.
 article
396 Migration and risk factors for alzheimer's presenile dementia in Scotland 1994
 15 S1 p. S75-
1 p.
 article
397 Minnesota family workshop: A psychoeducational approach for individuals with mild to moderate dementia and their families 1994
 15 S1 p. S107-
1 p.
 article
398 MKC-231, a novel choline uptake enhancer: Ameliorating effects on the memory deficits induced by AF64A in rats Bessho, T.
 1994
 15 S1 p. S103-
1 p.
 article
399 Modulation of Alzheimer's-like Tau phosphorylation in neonatal rat forebrain by phosphatase inhibitors and basic fibroblast growth factor 1994
 15 S1 p. S24-
1 p.
 article
400 Modulation of GSK-3-catalyzed phosphorylation of microtubule-associated protein tau by nonproline dependent protein kinases 1994
 15 S1 p. S37-
1 p.
 article
401 Modulation of the tau PHF-1 epitope in vitro 1994
 15 S1 p. S26-
1 p.
 article
402 Molecular analysis of the region on chromosome 14 associated with early-onset Alzheimer's disease Hutton, Michael L.
 1994
 15 S1 p. S129-
1 p.
 article
403 Molecular biology, genetics and protein chemistry of prion diseases 1994
 15 S1 p. S109-
1 p.
 article
404 Molecular characterization of the members of the APP like gene family 1994
 15 S1 p. S159-S160
2 p.
 article
405 Molecular dissection of the paired helical filament 1994
 15 S1 p. S31-S32
2 p.
 article
406 Molecular genetics of hereditary dysphasic dementia Lendon, C.L.
 1994
 15 S1 p. S128-
1 p.
 article
407 Molecular genetic studies of human prion disease 1994
 15 S1 p. S150-
1 p.
 article
408 Molecular mechanisms of free radical generation by β-amyloid peptides: EPR studies, molecular modeling, and neurotoxicity assays 1994
 15 S1 p. S55-
1 p.
 article
409 More does not necessarily mean better: The career of secondary caregivers 1994
 15 S1 p. S2-
1 p.
 article
410 Morphological study on the early stages of cerebral beta-amyloid deposits 1994
 15 S1 p. S70-
1 p.
 article
411 Mortality rates and causes of death among Alzheimer's disease patients in california 1994
 15 S1 p. S47-S48
2 p.
 article
412 MP100 - A new human metalloprotease with the ability to cleave substrates derived from the N-terminus of β-amyloid 1994
 15 S1 p. S142-
1 p.
 article
413 Multi-channel quantitative EEG (QEEG) in the diagnosis of Alzheimer's type dementia McKenzie, S.
 1994
 15 S1 p. S98-
1 p.
 article
414 Multiple etiologies for Alzheimer disease revealed by segregation analysis 1994
 15 S1 p. S126-S127
2 p.
 article
415 Multiple memory systems in mild and very mild dementia of the Alzheimer type 1994
 15 S1 p. S35-
1 p.
 article
416 Muscarinic cholinergic receptor changes in the hippocampus of adrenalectomized rats Islam, A.
 1994
 15 S1 p. S16-
1 p.
 article
417 Mutations associated with a locus for familial alzheimer's disease result in the production of truncated amyloid β-proteins 1994
 15 S1 p. S53-
1 p.
 article
418 N and C terminal truncation of tau in Alzheimer's disease 1994
 15 S1 p. S21-
1 p.
 article
419 Neeurofilament pathology in Alzheimer's disease Takeda, M.
 1994
 15 S1 p. S139-
1 p.
 article
420 Nerve growth factor mRNA levels are normal in Alzheimer's disease 1994
 15 S1 p. S123-
1 p.
 article
421 Neuritic plaques and neurofibrillary tangles in human brain identified by FT-IR spectroscopy Choo, L.-P.
 1994
 15 S1 p. S147-
1 p.
 article
422 Neurochemical profiles of non-Alzheimer neurodegenerative disorders 1994
 15 S1 p. S120-
1 p.
 article
423 Neurodegenerative effects induced by β-amyloid and PRP peptides: Similarities and differences Forloni, G.
 1994
 15 S1 p. S87-
1 p.
 article
424 Neuronal achromasia in neurodegenerative disease 1994
 15 S1 p. S112-
1 p.
 article
425 Neuronal localization of apolipoprotein E: A comparative study 1994
 15 S1 p. S118-
1 p.
 article
426 Neuron-specific alternative splicing of βA4-amyloid protein precursor (APP) and amyloid precursor-like protein 2 (APLP2) 1994
 15 S1 p. S59-S60
2 p.
 article
427 Neuropathological changes in rat brain injected with Alzheimer tau. Paired helical filaments, and amyloid cores 1994
 15 S1 p. S113-
1 p.
 article
428 Neuropathological findings in elderly drivers killed in traffic crashes 1994
 15 S1 p. S145-
1 p.
 article
429 Neuropathological recovery in chronic aluminum neurotoxicity is dependant on neurofilament phosphorylation state Strong, M.J.
 1994
 15 S1 p. S19-
1 p.
 article
430 Neuropathological scores of Alzheimer changes Kamphorst, W.
 1994
 15 S1 p. S110-
1 p.
 article
431 Neuropathological study of the rat brain after repetition of mild mechanical brain injury 1994
 15 S1 p. S116-S117
2 p.
 article
432 Neuropathologic findings in cognitively normal older adults 1994
 15 S1 p. S109-S110
2 p.
 article
433 Neuropeptidases and peptides catabolism in Alzheimer's disease 1994
 15 S1 p. S158-
1 p.
 article
434 Neuropsychological features of family members suffering from early onset chromosome 14 encoded Alzheimer's disease 1994
 15 S1 p. S9-
1 p.
 article
435 Neuropsychological functioning of former prisoners of war in old age 1994
 15 S1 p. S69-
1 p.
 article
436 Neurotoxic effects of an APOE-related synthetic peptide on dissociated embryonic chick sympathetic and cortical neurons 1994
 15 S1 p. S118-
1 p.
 article
437 Neurotoxicity of the prion protein Diedrich, J.F.
 1994
 15 S1 p. S157-
1 p.
 article
438 Neurotrophic factor therapy of Alzheimer's disease 1994
 15 S1 p. S82-
1 p.
 article
439 New method for the measurement of ADAP in human brain extracts 1994
 15 S1 p. S95-
1 p.
 article
440 New possibilities in the treatment of patients with Alzheimer disease 1994
 15 S1 p. S101-
1 p.
 article
441 New radioligands for pet-examination of central muscarinic receptors Farde, L
 1994
 15 S1 p. S105-
1 p.
 article
442 NGF-stimulation of ERKs in undifferentiated PC12 cells does not lead to PHF-type tau-hyperphosphorylation 1994
 15 S1 p. S26-S27
2 p.
 article
443 Nine-year longitudal course of aging and alzheimer's disease in community-residing subgroups 1994
 15 S1 p. S28-
1 p.
 article
444 NMDA activation increases tau phosphorylation in primary neuronal cultures: an immunoblot study 1994
 15 S1 p. S26-
1 p.
 article
445 NMDA increases phosphorylated tau immunoreactivity in primary neuronal cultures: a confocal laser microscopic study 1994
 15 S1 p. S26-
1 p.
 article
446 No correlation between clinical heterogeneity and codon 129 polymorphism of the prion protein gene (PRNP) in Gerstmann-Straussler-Scheinker Syndrome (GSS) with PRNP codon 102 mutation Barbanti, P.
 1994
 15 S1 p. S156-
1 p.
 article
447 No linkage to the Apolipoprotein E gene in Swedish Alzheimer disease families 1994
 15 S1 p. S133-
1 p.
 article
448 Noninvasive imaging using a murine monoclonal anti-Aβ antibody FAB labeled with technetium 99m in Alzheimer's disease 1994
 15 S1 p. S96-S97
2 p.
 article
449 Non-recognition of dementia by caregivers; frequency and correlates in the Honolulu heart program cohort 1994
 15 S1 p. S45-
1 p.
 article
450 Non-steroidal anti-inflammatory drug use and Alzheimer's disease in Rochester, Minnesota 1994
 15 S1 p. S45-
1 p.
 article
451 Normal aging versus very mild Alzheimer's disease: Clinicopathologic distinctions Morris, JC
 1994
 15 S1 p. S140-
1 p.
 article
452 Novel biochemical properties of the brain ERK kinase PK40erk 1994
 15 S1 p. S37-
1 p.
 article
453 Observation of possible intermediates in the conversion of PRPC to scrapie amyloid (PRPSc) 1994
 15 S1 p. S151-
1 p.
 article
454 Occupational exposure to electromagnetic fields is associated with increased risk of alzheimer's disease 1994
 15 S1 p. S74-
1 p.
 article
455 Overexpression of human tau441 in PC12 and cho cells 1994
 15 S1 p. S17-
1 p.
 article
456 Oxidative damage to mitochondrial DNA in Alzheimer's disease 1994
 15 S1 p. S124-S125
2 p.
 article
457 Pancreatic or “neuronal” thread protein in cerebrospinal fluid: Analyses using a clinical neurochemical approach 1994
 15 S1 p. S94-S95
2 p.
 article
458 Partial M1 but not M3 muscarinic agonists reverse scopolamine-induced memory impairment in rats 1994
 15 S1 p. S103-
1 p.
 article
459 Participatory control and the well-being of family caregivers 1994
 15 S1 p. S107-
1 p.
 article
460 Parvalbumin and calretinin immunoreactivity in the primary visual cortex and lateral geniculate nucleus of control and Alzheimer brains 1994
 15 S1 p. S112-S113
2 p.
 article
461 Pharmacodynamic effects of repeated oral administration of 4 different doses of S12024-2 (Cognitive Enhancer) in 36 healthy elderly volunteers 1994
 15 S1 p. S100-
1 p.
 article
462 Phenotypal subgroups of Alzheimer's disease. Relevance for clinical course and survival 1994
 15 S1 p. S7-
1 p.
 article
463 Phenotypic characterization of chromosome 14-linked familial Alzheimer's disease 1994
 15 S1 p. S35-S36
2 p.
 article
464 PHF-1 immunopositive dystrophic neurites are preferentially associated with thioflavine positive β-pleated plaques and not diffuse amyloid plaques 1994
 15 S1 p. S152-
1 p.
 article
465 Phospholipid composition of plasma membrane preparations from control and Alzheimer brain 1994
 15 S1 p. S122-S123
2 p.
 article
466 Phosphorylation of human Tau protein following expression in baculovirus-infected SF-9 cells 1994
 15 S1 p. S25-
1 p.
 article
467 Phosphorylation of Tau in transiently transfected control and Raf transformed 3T3 cells Latimer, DA
 1994
 15 S1 p. S25-
1 p.
 article
468 Phosphorylation sites in tau protein and paired helical filaments 1994
 15 S1 p. S23-
1 p.
 article
469 Physiological production of amyloid β-peptide as a route to the mechanism and treatment of Alzheimer's disease 1994
 15 S1 p. S69-S70
2 p.
 article
470 Polarized secretion of β-amyloid precursor protein and amyloid-β peptide in MDCK cells 1994
 15 S1 p. S65-
1 p.
 article
471 Positional cloning of candidate genes on chromosome 14 linked to early onset Alzheimer's disease 1994
 15 S1 p. S149-
1 p.
 article
472 Possible benefits of a combination of selegiline and cholinesterase inhibitors 1994
 15 S1 p. S67-
1 p.
 article
473 Post-translational protein modification and crosslinking in alzheimer disease 1994
 15 S1 p. S78-S79
2 p.
 article
474 Predicting aberrant behaviors in Alzheimer's disease 1994
 15 S1 p. S106-
1 p.
 article
475 Prediction of driving in Alzheimer's patients with neuropsychologic testing 1994
 15 S1 p. S106-
1 p.
 article
476 Predictive testing for inherited prion disease 1994
 15 S1 p. S107-
1 p.
 article
477 Predictive Value of Apolipoprotein E genotyping in Alzheimer's disease: Results of an Autopsy Series 1994
 15 S1 p. S134-
1 p.
 article
478 Prevalence of Alzheimer's disease and vascular dementia in the rotterdam study 1994
 15 S1 p. S40-
1 p.
 article
479 Prevalence of dementia in Canada 1994
 15 S1 p. S67-S68
2 p.
 article
480 Prevalence of dementia in troina, Sicily 1994
 15 S1 p. S40-
1 p.
 article
481 Prion (Creutzfeld-Jakob) Disease: A retrospective neuropathological investigation with implications for future research Bruton, C.J.
 1994
 15 S1 p. S88-
1 p.
 article
482 Probable AP-2 binding sequence within exon-1 of human and porcine choline acetyltransferase genes regulates transcription in neural cells 1994
 15 S1 p. S129-
1 p.
 article
483 Processing of normal and mutant amyloid β protein precursors 1994
 15 S1 p. S76-
1 p.
 article
484 Production of β-protein in canine vascular myocytes in long-term cultures 1994
 15 S1 p. S52-
1 p.
 article
485 Proline substitutions in beta peptide fragments eliminate both fibril formation and cellular toxicity 1994
 15 S1 p. S50-
1 p.
 article
486 Proteinase-resistant prion protein in fatal familial insomnia: Regional distribution and correlation with histopathology 1994
 15 S1 p. S88-S89
2 p.
 article
487 Protein glycosylation changes in Alzheimer's disease Gillian, A.M.
 1994
 15 S1 p. S83-
1 p.
 article
488 Protein kinase C dependent processing of the Alzheimer's amyloid precursor protein 1994
 15 S1 p. S53-
1 p.
 article
489 Protein oxidation in cerebral microvessels in Alzheimer's disease 1994
 15 S1 p. S124-
1 p.
 article
490 β Protein precursor interaction with τ 1994
 15 S1 p. S78-
1 p.
 article
491 β Protein precursor (βPP) mRNA in smooth muscle cells isolated from dog leptomeningeal vessels Kujawa, M.
 1994
 15 S1 p. S60-
1 p.
 article
492 Proteoglycan association with Aβ: A possible cause of senile plaque accumulation and persistence 1994
 15 S1 p. S152-
1 p.
 article
493 Prothrombin activation in brains of patients with Alzheimer's disease 1994
 15 S1 p. S124-
1 p.
 article
494 PrP gene mutations and subtypes of hereditary prion diseases 1994
 15 S1 p. S151-
1 p.
 article
495 Psychometric discrimination of mild dementia in an African-American sample 1994
 15 S1 p. S91-
1 p.
 article
496 Psychometric validity and screening utility of the cognitive abilities screening instrument (CASI): preliminary data from study of guamanian chamorros 1994
 15 S1 p. S42-S43
2 p.
 article
497 Psychotic symptoms in Alzheimer's disease and their relation to cognitive and functional decline 1994
 15 S1 p. S35-
1 p.
 article
498 Pure multi-infarct dementia rarely mimics Alzheimer's disease throughout its course: A clinicopathologic study 1994
 15 S1 p. S99-
1 p.
 article
499 Purification and characterization of forms of sβPP specifically cleaved at α-secretase or β-secretase sites 1994
 15 S1 p. S63-S64
2 p.
 article
500 Quantitative assessment of cortical synaptic density in patients with Alzheimer's disease and non-demented individuals with heart disease Scheff, S.W.
 1994
 15 S1 p. S151-S152
2 p.
 article
501 Quantitative MRI brain volumetry in a Swedish family with the APP 670/671 mutation 1994
 15 S1 p. S10-
1 p.
 article
502 Quantitative neuropathology in Alzheimer disease: Neuronal loss in high order association cortex parallels dementia 1994
 15 S1 p. S141-
1 p.
 article
503 Questions and answers on home care for dementia patients: Introduction of a semi-structured interview for the assessment of the subjective burden of family caregivers 1994
 15 S1 p. S2-S3
2 p.
 article
504 Rapid apolipoprotein E genotyping by the “Affigene APOE kit” 1994
 15 S1 p. S135-
1 p.
 article
505 Rapid dephosphorylation of tau protein in both female and male heat-shocked rats and subsequent hyperphosphorylation only in female rats. Implications for the etiopathogenesis of Alzheimer's disease 1994
 15 S1 p. S34-
1 p.
 article
506 Rate of progression of Alzheimer disease is associated with genetic risk 1994
 15 S1 p. S28-
1 p.
 article
507 Rationale for the use of selegiline in the treatment of Alzheimer's disease 1994
 15 S1 p. S66-
1 p.
 article
508 Recognition memory for faces and recollective experience in Alzheimer's disease (AD) 1994
 15 S1 p. S106-
1 p.
 article
509 Reduced cerebrovascular responsivity (CVR) to acetazolamide in dementia of Alzheimer's type (DAT) 1994
 15 S1 p. S97-
1 p.
 article
510 Reduced enzyme activities in Alzheimer's disease are sensitive to hypoxia 1994
 15 S1 p. S120-
1 p.
 article
511 Reduction of APP levels in PC12 cells treated with anti-sense oligonucleotide 1994
 15 S1 p. S17-S18
2 p.
 article
512 Reduction of brain aluminum by desferrioxamine and relevance to Alzheimer's disease 1994
 15 S1 p. S137-
1 p.
 article
513 Regional analysis of NGF protein levels in Alzheimer's disease: Relation to chat activity 1994
 15 S1 p. S123-
1 p.
 article
514 Regulated APPS release from rat brain slices 1994
 15 S1 p. S63-
1 p.
 article
515 Regulated cleavage of the amyloid precursor protein (APP): Molecular and cellular basis 1994
 15 S1 p. S39-
1 p.
 article
516 Regulated phosphorylation of APP in vivo Oishi, M.
 1994
 15 S1 p. S84-
1 p.
 article
517 Regulation of βA4 generation from the amyloid protein precursor and fragments thereof 1994
 15 S1 p. S62-S63
2 p.
 article
518 Regulation of β-amyloid precursor protein (βAPP) gene in cultured normal human muscle fibers 1994
 15 S1 p. S158-S159
2 p.
 article
519 Regulation of β-amyloid production and neurotoxicity in human cortical culture 1994
 15 S1 p. S31-
1 p.
 article
520 Regulation of APP processing by cell surface receptors 1994
 15 S1 p. S75-S76
2 p.
 article
521 Relationships between past cigarette smoking status and cognitive functions in healthy aging 1994
 15 S1 p. S47-
1 p.
 article
522 Relative RNA message abundance in control and Alzheimer's disease (AD) affected human neocortex 1994
 15 S1 p. S22-
1 p.
 article
523 Removal of liquid-phase and substrate-bound amyloid β peptide (Aβ) by microglia and other CNS cell types 1994
 15 S1 p. S152-
1 p.
 article
524 Resistance to beta-A4 neurotoxicity in PC12 cells 1994
 15 S1 p. S141-
1 p.
 article
525 Sabeluzole, a prototype drug targeted at the aberrant cytoskeleton 1994
 15 S1 p. S24-
1 p.
 article
526 Safety, tolerance, and pharmacokinetics of xanomeline tartrate, a novel muscarinic M1 agonist in healthy elderly subjects 1994
 15 S1 p. S104-
1 p.
 article
527 Secretion of amyloid β-protein by a mouse neuronal cell line 1994
 15 S1 p. S50-S51
2 p.
 article
528 Secretory form of Alzheimer amyloid precursor protein is more abundant in the cerebral white matter than in the gray matter 1994
 15 S1 p. S64-
1 p.
 article
529 Selection of suppressors of neurotoxicity mediated by the β-amyloid precursor protein: The development of a cell culture system 1994
 15 S1 p. S83-
1 p.
 article
530 Selective agonists at M1 cholinoceptors: Leads from muscarinic toxins from mamba snake venoms 1994
 15 S1 p. S102-
1 p.
 article
531 Selective loss of inositol(1,4,5)trisphosphate (IP3) but not inositol(1,3,4,5)tetrakiphosphate (IP4) receptor sites in the Alzheimer's disease brain Garlind, Anita
 1994
 15 S1 p. S126-
1 p.
 article
532 Selective medial and lateral temporal lobe pathology in cases at-risk for AD: Diagnostic role of pet 1994
 15 S1 p. S146-S147
2 p.
 article
533 Selegiline in Alzheimer's disease: A review 1994
 15 S1 p. S67-
1 p.
 article
534 Separate regulation of α- and β-secretase activity by phorbol ester and the Swedish mutation are independent of the bulk of the APP ectodomain 1994
 15 S1 p. S84-S85
2 p.
 article
535 Sequence analysis of amyloid precursor protein gene in Alzheimer's disease: Consensus sequences associated with alternative splicing of exons 7 and 8 1994
 15 S1 p. S131-
1 p.
 article
536 Serum α 1-antichymotrypsin concentrations in Alzheimer type- and vascular dementia Yoshida, Y.
 1994
 15 S1 p. S93-S94
2 p.
 article
537 Similarities and dissimilarities between altered neurites in senile plaques and neuropil threads in Alzheimer's disease; and between Alzheimer and non-demented elderly senile plaques 1994
 15 S1 p. S110-S111
2 p.
 article
538 Similar regional distribution of lewy bodies in Alzheimer and Parkinson disease 1994
 15 S1 p. S144-
1 p.
 article
539 Single and multiple dose safety, pharmacodynamics and pharmacokinetics of xanomeline, a novel muscarinic M1 agonist in healthy male subjects 1994
 15 S1 p. S104-S105
2 p.
 article
540 Skin vessel reactivity is impaired in Alzheimer's disease 1994
 15 S1 p. S92-
1 p.
 article
541 Solubilization of full length APP is mediated by an enzymatic mechanism 1994
 15 S1 p. S52-
1 p.
 article
542 Soluble amyloid β-protein (Aβ) is detected in alzheimer but not in normal brains 1994
 15 S1 p. S79-
1 p.
 article
543 Sorting of amyloid precursor protein in polarized and unpolarized cells 1994
 15 S1 p. S158-
1 p.
 article
544 Special care units in nursing homes: Expectations vs reality 1994
 15 S1 p. S3-
1 p.
 article
545 Specialized adult day center programs for Alzheimer's patients: Results of a national demonstration program 1994
 15 S1 p. S4-
1 p.
 article
546 Specific hippocampal atrophy in cases at-risk for ad: A volumetric MRI study 1994
 15 S1 p. S146-
1 p.
 article
547 Spontaneous abortions: more common among familial Alzheimer disease cases than sporadic cases 1994
 15 S1 p. S46-
1 p.
 article
548 Spontaneous language and impairment of communication in Alzheimer's disease 1994
 15 S1 p. S91-
1 p.
 article
549 Stimulative effect of β-amyloid protein(β/A4) on cyclic GMP-dependent lipid peroxide production in hippocampus 1994
 15 S1 p. S116-
1 p.
 article
550 Stopped-flow kinetics reveal multiple phases of thioflavine T binding to alzheimer β(1–40) & insulin amyloid 1994
 15 S1 p. S80-
1 p.
 article
551 Structural analysis of heparan sulfate from normal and amyloid-laden tissues 1994
 15 S1 p. S141-S142
2 p.
 article
552 Structural phenotypic and genotypic expression of apolipoprotein E in the pre-senile and senile dementias Bétard, C.
 1994
 15 S1 p. S154-S155
2 p.
 article
553 Structural prerequisites for amyloid fibrillogenesis 1994
 15 S1 p. S49-
1 p.
 article
554 Structural studies on tau protein and paired helical filaments by X-ray scattering, spectroscopy, and electron microscopy 1994
 15 S1 p. S20-S21
2 p.
 article
555 Structure and regulation of grworh inhibitory factor (GIF)-encoding gene 1994
 15 S1 p. S149-
1 p.
 article
556 Studies on the mechanism of B/A, toxicity 1994
 15 S1 p. S18-
1 p.
 article
557 Studies on the role of glycosylation on processing of the Alzheimer's amyloid precursor protein (APP) 1994
 15 S1 p. S84-
1 p.
 article
558 Studies on the structure and aggregation of synthetic βA4(1–40) amyloid peptide of Alzheimer's disease 1994
 15 S1 p. S49-
1 p.
 article
559 Study of mosaicism for chromosome 21 in skin fibroblast cultures from Alzheimer disease and control individuals 1994
 15 S1 p. S130-
1 p.
 article
560 Study on neurobehavioural defects in developing rats following in-utero exposure to aluminum 1994
 15 S1 p. S19-S20
2 p.
 article
561 Surface APP is not found on rapidly changing portions of neurites, including growth cones 1994
 15 S1 p. S63-
1 p.
 article
562 Survival analysis of patients with Alzheimer's disease on long term tacrine 1994
 15 S1 p. S29-
1 p.
 article
563 Systemic nature of Alzheimer's disease: Special reference to the cutaneous tissue 1994
 15 S1 p. S145-
1 p.
 article
564 Tacrine accumulates in the acidic cell compartments: Potential therapeutic implications 1994
 15 S1 p. S102-
1 p.
 article
565 Tacrine alters the processing of Alzheimer's beta-amyloid precursor protein in cell cultures 1994
 15 S1 p. S65-
1 p.
 article
566 Tau is a component of neuronal nuclei purified from Alzheimer's disease and control brain 1994
 15 S1 p. S23-
1 p.
 article
567 Tau isoform expression and phosphorylation state during neuronal differentiation 1994
 15 S1 p. S27-
1 p.
 article
568 Tau phosphorylation and dephosphorylation in human, primate, and rat brain slices 1994
 15 S1 p. S38-
1 p.
 article
569 Tau protein and PHFs: phosphorylation vs. structure 1994
 15 S1 p. S32-
1 p.
 article
570 Tau protein in cerebrospinal fluid: Diagnostic significance in dementia disorders 1994
 15 S1 p. S22-S23
2 p.
 article
571 Tau protein kinase will play the central role in alzheimer disease 1994
 15 S1 p. S76-S77
2 p.
 article
572 Temporal changes in the outbreak of amyotrophic lateral sclerosis/Parkinsonism-dementia complex, evaluation of Guamanian Chamorro controls 1994
 15 S1 p. S153-
1 p.
 article
573 Temporal quantification of Alzheimer's disease severity 1994
 15 S1 p. S6-S7
2 p.
 article
574 The amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E catalyze the assembly of the alzheimer β-protein into filaments and co-localize with APP at the neuromuscular junction 1994
 15 S1 p. S54-
1 p.
 article
575 The amyloid protein precursor in the developing and adult olfactory system 1994
 15 S1 p. S60-
1 p.
 article
576 The apolipoprotein E E4 allele is over-represented in the lewy body variant of Alzheimer's disease 1994
 15 S1 p. S154-
1 p.
 article
577 The association of the apolipoprotein E4 allele with Alzheimer's disease 1994
 15 S1 p. S133-
1 p.
 article
578 The atrophy of the hippocampal formation subdivisions correlates with duration and stage of Alzheimer disease 1994
 15 S1 p. S144-
1 p.
 article
579 The blood-brain barrier regulates transport of alzheimer's amyloid β and apolipoproteins E and J 1994
 15 S1 p. S80-
1 p.
 article
580 The calcium-dependent crosslinking of tau by transglutaminase: A possible role in neurofibrillary tangle formation 1994
 15 S1 p. S78-
1 p.
 article
581 The characteristic plaques and tangles: Continuity in the medical concept of senility 1994
 15 S1 p. S108-
1 p.
 article
582 The clinical diagnosis of vascular dementia: A comparison between seven currently used diagnostic criteria 1994
 15 S1 p. S90-
1 p.
 article
583 The cognitive battery for dementia in the diagnosis of Alzheimer's disease 1994
 15 S1 p. S90-S91
2 p.
 article
584 The differential role of the Alzheimer's association and a dementia clinic in addressing the community needs 1994
 15 S1 p. S108-
1 p.
 article
585 The distribution of β/A4 associated proteins in alzheimer's disease brains 1994
 15 S1 p. S79-
1 p.
 article
586 The effect of aluminum chloride on chromatin condensation in human short-term whole blood cultures 1994
 15 S1 p. S19-
1 p.
 article
587 The effects of muscarinic agonist xanomeline on human sleep 1994
 15 S1 p. S105-
1 p.
 article
588 The effects of tacrine in patients with mild versus moderate stage alzheimer's disease Farlow, M.
 1994
 15 S1 p. S81-
1 p.
 article
589 The effects of THA and nicotine on cognition in experimental models of Alzheimer's disease 1994
 15 S1 p. S30-
1 p.
 article
590 The endocytic pathway contributes to the production and release of amyloid β-protein 1994
 15 S1 p. S64-
1 p.
 article
591 The epidemiologic approach to dementia: The role of atherosclerosis 1994
 15 S1 p. S68-S69
2 p.
 article
592 The epidemiology and etiology of Alzheimer's disease as reported by scientists from 83 countries 1994
 15 S1 p. S48-
1 p.
 article
593 The epidemiology of Alzheimer's disease: Beyond risk factors 1994
 15 S1 p. S39-
1 p.
 article
594 The estimation of mental functions in the patients with Alzheimer disease 1994
 15 S1 p. S6-
1 p.
 article
595 The expressions of β-amyloid precursor protein mRNA are altered by CNTF, serum depletion in C6 glioma cells Sudoh, S.
 1994
 15 S1 p. S60-
1 p.
 article
596 The familial amyloid β protein precursor (βAPP717) mutations increase production of long amyloid β protein 1994
 15 S1 p. S54-S55
2 p.
 article
597 The first study of dementia within the cherokee nation of Oklahoma 1994
 15 S1 p. S41-
1 p.
 article
598 The functional rating scale (FRS) in Alzheimer disease assessment: A longitudinal study 1994
 15 S1 p. S8-
1 p.
 article
599 The genetics of Alzheimer's disease 1994
 15 S1 p. S149-
1 p.
 article
600 The heat-shock/oxidative stress connection: Production of free radicals by hyperthermia 1994
 15 S1 p. S72-
1 p.
 article
601 The immunopositive structure in Alzheimer's disease brain demonstrated with monoclonal antibody against APP carboxy terminal sequence 1994
 15 S1 p. S58-S59
2 p.
 article
602 The impact of the home environment on dementia caregiving Olsen, R.V.
 1994
 15 S1 p. S138-
1 p.
 article
603 The influence of cultural paradigms on scientific research of senile dementia 1994
 15 S1 p. S108-S109
2 p.
 article
604 The influence of prior and concurrent use of aspirin and vitamins on cognitive function scores in elderly Japanese-American men 1994
 15 S1 p. S74-
1 p.
 article
605 The inhibitory effect of β-amyloid peptide on rat brain Na/Ca exchange 1994
 15 S1 p. S82-S83
2 p.
 article
606 The meaning of caregiving for Alzheimer's disease among native american caregivers: stories of spirituality, fatalism, and mastery 1994
 15 S1 p. S107-S108
2 p.
 article
607 The metabolism of the βA4 amyloid precursor protein in Alzheimer's disease Masters, Colin L.
 1994
 15 S1 p. S69-
1 p.
 article
608 The modified ordinal scales of psychological development (M-OSPD) for the assessment of cognitive abilities in late stages of Alzheimer's disease (AD) 1994
 15 S1 p. S7-
1 p.
 article
609 The Netherlands memory & aging programma; results from a large cross-sectional population study 1994
 15 S1 p. S41-
1 p.
 article
610 The pathological lesions of Alzheimer's disease; form and formation 1994
 15 S1 p. S109-
1 p.
 article
611 The performance of the Italian version of ADAS in a clinical trial with Alzheimer's disease patients 1994
 15 S1 p. S7-
1 p.
 article
612 The possible role of herpes simplex virus type 1 in the aetiology of Alzheimer's disease 1994
 15 S1 p. S47-
1 p.
 article
613 The possible role of reactive astrocytes in amyloidogenesis 1994
 15 S1 p. S51-
1 p.
 article
614 The potential of degenerative disorder diagnosis based on biochemical pattern or profile analysis 1994
 15 S1 p. S95-
1 p.
 article
615 The precursor protein of non-Aβ component of Alzheimer's disease amyloid (NACP) is a presynaptic protein of the central nervous system 1994
 15 S1 p. S58-
1 p.
 article
616 The prion protein gene, a novel genetic locus and prion-specified information control regional patterns of PrPSc accumulation and neuropathology in mice 1994
 15 S1 p. S157-
1 p.
 article
617 Therapy with a combination of iron, vitamin B6 and coenzyme Q10 in the long term for sporadic Alzheimer's disease 1994
 15 S1 p. S101-
1 p.
 article
618 The relationship of diabetes and glucose tolerance to cognitive function 1994
 15 S1 p. S45-
1 p.
 article
619 The respite continuum: User characteristics and policy implications 1994
 15 S1 p. S3-
1 p.
 article
620 The role of apo E in amyloid fibril formation 1994
 15 S1 p. S143-
1 p.
 article
621 The role of microglia in the formation of senile plaques 1994
 15 S1 p. S122-
1 p.
 article
622 The role of zinc in Aβ amyloidosis 1994
 15 S1 p. S50-
1 p.
 article
623 The safety and tolerance of Xanomeline tartrate an M1-specific cholinergic agonist, in patients with Alzheimer's disease Cutler, NR
 1994
 15 S1 p. S104-
1 p.
 article
624 The solution structure of the amyloid β-peptide displays a striking resemblance to alamethicin and mellitin 1994
 15 S1 p. S48-
1 p.
 article
625 The structure of social engagement among nursing home residents 1994
 15 S1 p. S136-
1 p.
 article
626 The tissue distribution of amyloid protein precursor immunoreactivity in rodents 1994
 15 S1 p. S59-
1 p.
 article
627 The use of bound autochthonous IgM on T cells as a diagnostic marker for Alzheimer's disease 1994
 15 S1 p. S93-
1 p.
 article
628 The use of selegeline in Parkinson's and Alzheimer's disease — common links 1994
 15 S1 p. S67-
1 p.
 article
629 The way to ideal brain banking in Alzheimer's disease is paved with matching factors 1994
 15 S1 p. S143-
1 p.
 article
630 Thrombin induces secretion and proteolytic processing of protease nexin-2/amyloid β-protein precursor in cultured cells 1994
 15 S1 p. S66-
1 p.
 article
631 Tissue distribution and cellular localisation of hyperphosphorylated tau in human head injury and aged matched controls 1994
 15 S1 p. S22-
1 p.
 article
632 Trafficking and metabolism of the “Swedish” APP variant 1994
 15 S1 p. S76-
1 p.
 article
633 Trafficking and processing of amyloid precursor protein (APP) in polarized epithelial cells 1994
 15 S1 p. S65-
1 p.
 article
634 Transdermal nicotine administration in alzheimer's disease: Effects on cognition, behavior, and cardiac function 1994
 15 S1 p. S81-
1 p.
 article
635 Transforming growth factor β1 (TGFβ) modification of β protein immunoreactivity in the hippocampus with and without β protein infusion and the resulting ultrastructural neuropathology 1994
 15 S1 p. S55-S56
2 p.
 article
636 Transgenic Caenorhabditis elegans as model system to study amyloid formation and toxicity 1994
 15 S1 p. S33-
1 p.
 article
637 Transgenic mice expressing human Alzheimer's β-amyloid precursor protein produce high amounts of β-peptide 1994
 15 S1 p. S12-
1 p.
 article
638 Transgenic mice expressing human APP derived transgenes 1994
 15 S1 p. S11-
1 p.
 article
639 Transgenic mice that overproduce a C-terminal region of β-amyloid precursor protein 1994
 15 S1 p. S30-
1 p.
 article
640 Transthyretin sequesters amyloid β protein and prevents amyloid formation 1994
 15 S1 p. S53-S54
2 p.
 article
641 Treatment strategies for Alzheimer's disease 1994
 15 S1 p. S39-S40
2 p.
 article
642 Truncated forms of prion protein in human brain and cell lines 1994
 15 S1 p. S89-
1 p.
 article
643 Tumor necrosis factor alpha (TNF-α) is involved in the pathogenesis of the panencephalopathic type of Creutzfeldt-Jakob Disease (CJD) 1994
 15 S1 p. S88-
1 p.
 article
644 Twisted ribbon structure of paired helical filaments revealed by atomic force microscopy 1994
 15 S1 p. S20-
1 p.
 article
645 Ubiquitinated Dot-Profiles (UDP) are decreased in the hippocampus in Alzheimer's disease compared with Lewy body dementia, Parkinson's disease, and controls 1994
 15 S1 p. S114-
1 p.
 article
646 Ubiquitin immunoreactive CA2-3 neurites in hippocampus coexist with cortical Lewy bodies 1994
 15 S1 p. S114-
1 p.
 article
647 Ultrastructure of the readily soluble paired helical filaments (PHF I) and non-PHF abnormally phosphorylated tau (Ad P Tau) 1994
 15 S1 p. S20-
1 p.
 article
648 Validity and reliability of surgical history obtained by interview from proxy respondents in epidemiologic studies of Alzheimer's disease 1994
 15 S1 p. S43-
1 p.
 article
649 Variations in the neuronal glutamate transporter protein may play a rôle in the localized excitotoxicity of Alzheimer disease 1994
 15 S1 p. S119-S120
2 p.
 article
650 Volumes of hippocampus, amygdala, and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes 1994
 15 S1 p. S134-
1 p.
 article
651 Volumes of hippocampus and amygdala in the MRI-based diagnosis of early Alzheimer's disease 1994
 15 S1 p. S146-
1 p.
 article
652 What have we learned from paired helical filaments (PHF)? 1994
 15 S1 p. S6-
1 p.
 article
653 When is a special care unit a special care unit?: Classifying care arrangements in Minnesota nursing homes 1994
 15 S1 p. S3-S4
2 p.
 article
654 White matter change in an animal model of chronic cerebral hypoperfusion Kurumadani, T.
 1994
 15 S1 p. S15-
1 p.
 article
655 White matter changes aggravate Alzheimer's disease 1994
 15 S1 p. S143-S144
2 p.
 article
656 Xanomeline: A potent and selective M1 muscarinic agonist in vitro Mitch, CH
 1994
 15 S1 p. S104-
1 p.
 article
657 Xanomeline, a potent and specific M1 agonist in the treatment of mild and moderate Alzheimer's disease 1994
 15 S1 p. S148-
1 p.
 article
                             657 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands